摘要:
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
摘要:
A process for preparing a cyclic ester or a cyclic amide includes contacting hydroxycarboxylic acid and/or amino-carboxylic acid, an ester thereof, or a salt thereof, with acidic zeolite. The hydroxycarboxylic acid is a 2- or 6-hydroxycarboxylic acid, and the amino carboxylic acid is a 2- or 6-amino-carboxylic acid. The zeolite may include two or three interconnected and non-parallel channel systems, in which a channel system includes 10- or more-membered ring channels, and in which a framework Si/X2 ratio is at least 24 as measured by NMR. X is Al or B. The zeolite may include three interconnected and non-parallel channel systems, in which at least two channel systems include 10- or more-membered ring channels, and in which a framework Si/X2 ratio is at least 6 as measured by NMR. The process may be performed at a pressure between 0.5 and 20 bar.
摘要:
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
摘要:
Compounds of the general structure S-1, wherein X and R1-R5 are defined in the specification, are capable of abrogating the deubiquitinating (DUB) activity of the 19S RP DUBs and are useful in methods and compositions for treating cancer, in particular, cancer tumors refractory to treatment by state-of-the-art chemotherapy.
摘要翻译:通常结构S-1的化合物,其中X和R 1 -R 5在说明书中定义,能够消除19S RP DUB的去泛素化(DUB)活性,并且可用于治疗癌症的方法和组合物, 通过最先进的化学疗法治疗难治的癌症肿瘤。
摘要:
The present disclosure is directed to a reactive ester agent for conjugating a click-reactive group to a carrier molecule or solid support. The reactive ester agent has the general formula IA, wherein the variables R1, R2, R3, Ra and L are described throughout the application.
worin R¹-R⁹, R¹⁵, A, X, Y, Z und an die in der Beschreibung angegebene Bedeutung haben, sind wirksam als Protein kinase-Hemme und können als Heilmittel, insbesondere zur Behandlung entzündlicher Hauterkrankungen, und von Alopezie verwendet werden.
摘要:
Reagents, compounds useful for producing the reagents and fluorescence polarization immunoassay utilizing the reagents, for determining tricyclic antidepressants in biological fluids, are disclosed.
摘要:
Disclosed are compounds having the formula: wherein X, Y, Z1, Z2, Z3, Z4, R5, RA, m, A, L, and B are as defined herein, and methods of making and using the same.